GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of why does nobody talk about EU — 48 comments in the full submission. View in context.
1.2k
c/glp1eu·submitted 11 months ago by u/cormac_erdogan

why does nobody talk about EU

Questionbranch of 8 comments

why does nobody talk about EU. If this has been answered properly somewhere, link me and I will delete. On cross-border prescriptions, since the assumption behind half these threads is wrong. There are EU rules on the recognition of prescriptions issued in another member state, and they are conditional: the…

Read the full submission and all 48 comments →

This branch

8 comments, started 11 months ago
u/zaid_grimaldi184 points·11 months ago

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

replysharereportpermalink
u/lucia_bruun0 points·11 months ago

Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.

replysharereportpermalink
u/zeynep_weiss1 point·11 months ago

Cosigning on cross-border prescriptions. The rules exist and they are narrower than the summaries suggest.

replysharereportpermalink
u/nl_verzekering1 point·11 months ago

Cosigning on cross-border prescriptions.

This is the split the whole board depends on. Authorisation is European; payment is national.

replysharereportpermalink
u/tuva_aalto2 points·11 months ago·edited

Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.

replysharereportpermalink
u/greta_nilsen0 points·11 months ago

Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.

Adding the practical step — read your own country’s published criteria. They exist and they are definitive.

replysharereportpermalink
load more comments (2) →

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/glp1eu
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/eu_apotheke_au/nl_verzekeringu/nordic_pricingu/spain_receta
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →